Wall Street Analysts Believe Exact Sciences (EXAS) Could Rally 34.33%: Here's is How to Trade

Core Viewpoint - Exact Sciences (EXAS) shows potential for significant upside based on analysts' price targets and earnings estimate revisions, despite skepticism surrounding the reliability of price targets [1][2][5]. Price Targets - The mean price target for EXAS is $79.40, indicating a 34.3$59.11 [1]. - Price targets range from a low of $61 to a high of$100, with a standard deviation of $9.54, suggesting a moderate level of agreement among analysts [1][4]. - The lowest estimate indicates a 3.2% increase, while the highest suggests a 69.2% upside [1]. Earnings Estimates - Analysts have shown strong agreement in revising EPS estimates higher, which correlates with potential stock price movements [5]. - The Zacks Consensus Estimate for the current year has increased by 5% over the past month, with one estimate rising and no negative revisions [5]. - EXAS holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors [5]. Analyst Behavior - Analysts' price targets can often be overly optimistic due to business incentives, which may inflate targets for companies with existing relationships [3]. - A low standard deviation in price targets indicates a high degree of agreement among analysts regarding price movement direction, although it does not guarantee reaching the average target [4].